Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Retained Earnings (2016 - 2025)

Bioadaptives' Retained Earnings history spans 8 years, with the latest figure at -$10.7 million for Q4 2025.

  • On a quarterly basis, Retained Earnings fell 17.0% to -$10.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$10.7 million, a 17.0% decrease, with the full-year FY2025 number at -$10.7 million, down 17.0% from a year prior.
  • Retained Earnings hit -$10.7 million in Q4 2025 for Bioadaptives, down from -$9.9 million in the prior quarter.
  • Over the last five years, Retained Earnings for BDPT hit a ceiling of -$6.1 million in Q1 2021 and a floor of -$10.7 million in Q4 2025.
  • Historically, Retained Earnings has averaged -$8.1 million across 5 years, with a median of -$8.0 million in 2023.
  • Biggest five-year swings in Retained Earnings: fell 22.04% in 2021 and later dropped 6.28% in 2023.
  • Tracing BDPT's Retained Earnings over 5 years: stood at -$6.7 million in 2021, then fell by 13.45% to -$7.6 million in 2022, then decreased by 9.43% to -$8.3 million in 2023, then dropped by 10.88% to -$9.2 million in 2024, then dropped by 17.0% to -$10.7 million in 2025.
  • Business Quant data shows Retained Earnings for BDPT at -$10.7 million in Q4 2025, -$9.9 million in Q3 2025, and -$9.5 million in Q2 2025.